NCT06826768 2026-03-04A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPCM.D. Anderson Cancer CenterPhase 1 Recruiting60 enrolled
NCT06052852 2025-11-17Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesBolt Biotherapeutics, Inc.Phase 1 Terminated17 enrolled
NCT03477864 2025-04-29Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate CancerThomas Jefferson UniversityPhase 1 Withdrawn